tiprankstipranks
Trending News
More News >
Xero Limited (AU:XRO)
ASX:XRO

Xero Limited (XRO) AI Stock Analysis

Compare
381 Followers

Top Page

AU:XRO

Xero Limited

(Sydney:XRO)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
AU$79.00
▼(-1.21% Downside)
Action:UpgradedDate:02/05/26
The score is primarily supported by strong financial performance (high margins and accelerating free cash flow) and a positive earnings update with healthy growth/Rule of 40. Offsetting this, technical indicators point to a pronounced downtrend with weak momentum, and the valuation remains high (P/E ~51.8), which increases downside risk if growth or profitability disappoint.
Positive Factors
Revenue growth & margins
Xero delivered ~21.6% revenue growth in 2025 with a very high gross margin (~89%), reflecting its recurring subscription model and low incremental costs. Durable high gross margins on subscription revenue support sustainable profitability and reinvestment in product and ecosystem development.
Cash generation
Material free cash flow growth (+37.9% YoY) and an operating cash flow to net income ratio of 3.56 indicate strong cash conversion. Durable cash generation gives Xero flexibility to fund product development, integration of acquisitions, and balance-sheet management without relying on equity financing.
U.S. expansion via Melio
The Melio acquisition materially strengthens Xero's U.S. payments and bill-pay capabilities, with Melio growing 68%. Integrating bill-pay into Xero by Dec 2025 expands the platform's value proposition, enabling deeper monetization, higher retention, and structural entry into larger US SMB payments flows.
Negative Factors
Rising churn
An uptick in MRR churn to 1.09% signals pressure on retention that can persist as Xero targets higher-churn customer segments. For subscription models, higher churn erodes lifetime value, forces greater acquisition spend, and can structurally reduce margin tailwinds unless retention is restored.
Acquisition-driven leverage
Management expects the Melio deal to move Xero toward net debt from a prior net cash position. Higher leverage is a durable concern: it can constrain strategic flexibility, increase interest costs, and risk pressuring Rule of 40 outcomes if integration synergies or revenue uplifts take longer than planned.
Regional softness (Canada)
Subdued performance in Canada highlights geographic variability in adoption and growth execution. Persistent regional softness can require sustained, higher investment in sales, local product features, or pricing adjustments, reducing margin scalability and slowing international expansion durability.

Xero Limited (XRO) vs. iShares MSCI Australia ETF (EWA)

Xero Limited Business Overview & Revenue Model

Company DescriptionXero Limited, together with its subsidiaries, operates as a software as a service company in New Zealand, Australia, the United Kingdom, and internationally. The company offers Xero, an open platform that connects small businesses to a range of solutions, which helps to manage their finances. It also provides Xero mobile app; and accountant/bookkeeper tools, including Xero HQ, Xero Practice Manager, Xero Workpapers, and Xero Cashbook or Xero Ledger. Xero Limited was incorporated in 2006 and is headquartered in Wellington, New Zealand.
How the Company Makes MoneyXero generates revenue primarily through subscription fees for its cloud-based accounting software. The company offers various pricing tiers based on the features and services included, catering to businesses of different sizes and needs. Additionally, Xero earns revenue through add-on services and integrations with third-party applications, as well as through partnerships with financial institutions and accountants who promote its platform to their clients. Continuous investment in product development and marketing also play a significant role in driving customer acquisition and retention, thereby contributing to its overall earnings.

Xero Limited Earnings Call Summary

Earnings Call Date:Nov 12, 2025
(Q2-2026)
|
% Change Since: |
Next Earnings Date:May 14, 2026
Earnings Call Sentiment Positive
Xero's earnings call presented a generally positive outlook, with strong revenue growth across major regions and successful strategic initiatives like the Melio acquisition. However, challenges such as increased churn and specific regional issues in Canada were noted. Despite these, the overall financial health and strategic positioning of Xero appear robust.
Q2-2026 Updates
Positive Updates
Strong Revenue Growth
Operating revenue grew 20% year-over-year to $1.194 billion, or 18% in constant currency, demonstrating sustained growth despite tough prior comparisons.
Regional Success
Australia delivered 19% revenue growth with subscribers up 9%. The UK and North America also showed strong performance with 25% and 21% revenue growth, respectively.
International Segment Growth
The International segment, including the U.K., North America, and Rest of World markets, saw a 24% revenue increase year-over-year, highlighting strong execution against strategic priorities.
Melio Acquisition and Integration
Completion of the Melio acquisition in October is expected to accelerate growth in the U.S. market, with plans to integrate Melio bill pay into Xero by December 2025.
Rule of 40 Achievement
Xero delivered a Rule of 40 outcome of 44.5%, an increase of 0.6 percentage points year-over-year, indicating strong cash generation and balanced growth.
Negative Updates
Churn Increase
MRR churn was 1.09%, slightly increasing from the last half, reflecting targeted growth in higher-churn segments.
Challenges in Canada
Revenue growth in North America was lower than expected, partly due to a subdued market in Canada and the absence of revenue from Xerocon.
Impact of Noncash Costs
General and administration costs increased by 2.4 percentage points due to higher executive personnel costs, affecting overall EBITDA margins.
Company Guidance
In the Xero Limited 2026 Interim Results Conference Call, significant guidance and metrics were shared. The company reported a 20% year-over-year increase in operating revenue, reaching $1.194 billion, with adjusted EBITDA rising by 12% to $351 million. The Rule of 40 outcome improved to 44.5%, highlighting strong cash generation. The ANZ region, including Australia and New Zealand, saw robust revenue growth, with Australia achieving a 19% increase. International markets, notably the U.K. and North America, showed impressive revenue growth of 24% and 21% respectively, despite challenges such as the absence of Xerocon revenue. The acquisition of Melio was highlighted as a strategic move to bolster U.S. operations, with Melio achieving 68% revenue growth. The company also reported a free cash flow margin of 26.9% and a $3.2 billion net cash position, reflecting disciplined financial management. Anticipated impacts from the Melio acquisition include a shift to a net debt position, which may affect the Rule of 40 performance in the latter half of fiscal '26. Overall, Xero demonstrated a strategic balance of revenue growth and profitability, underscoring a positive outlook for sustained financial performance.

Xero Limited Financial Statement Overview

Summary
Strong fundamentals supported by ~21.6% revenue growth (2025) and very high gross margin (89.1%). Cash generation is a key strength (free cash flow +37.9% YoY; operating cash flow to net income 3.56). Balance sheet is solid with moderate leverage (debt-to-equity 0.61), though rising debt is a watch item and net margin (10.8%) has room to improve.
Income Statement
85
Very Positive
Xero Limited demonstrates robust growth with a significant revenue increase from 2024 to 2025, reflecting a 21.56% growth rate. The gross profit margin is strong at 89.05% for 2025, indicating effective cost management. However, the net profit margin, while positive at 10.84% in 2025, shows room for improvement compared to industry leaders. EBIT and EBITDA margins are healthy, reflecting operational efficiency.
Balance Sheet
78
Positive
The company's balance sheet is solid, with a debt-to-equity ratio of 0.61 in 2025, indicating moderate leverage. Return on Equity (ROE) is impressive at 10.38%, suggesting effective use of equity capital. The equity ratio stands at 49.19%, providing a healthy buffer against liabilities. However, the increase in total debt over the years suggests a need for cautious leverage management.
Cash Flow
82
Very Positive
Xero Limited's cash flow is strong, with a significant increase in free cash flow by 37.85% from 2024 to 2025. The operating cash flow to net income ratio is robust at 3.56, indicating efficient cash generation relative to net income. The free cash flow to net income ratio is also healthy at 2.31. These metrics suggest strong cash flow management, providing flexibility for future investment and debt servicing.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.34B1.91B1.57B1.40B1.12B848.78M
Gross Profit1.92B1.70B1.43B989.43M810.40M616.76M
EBITDA644.63M697.39M510.98M105.70M49.51M77.61M
Net Income272.41M207.03M160.21M-113.53M-9.11M19.69M
Balance Sheet
Total Assets6.10B4.06B2.95B2.33B2.35B2.02B
Cash, Cash Equivalents and Short-Term Investments4.21B2.12B1.53B1.05B870.02M1.11B
Total Debt1.18B1.22B1.22B1.07B949.03M951.21M
Total Liabilities2.09B2.06B1.56B1.34B1.31B1.28B
Stockholders Equity4.01B2.00B1.39B986.53M1.04B745.95M
Cash Flow
Free Cash Flow970.56M799.66M585.17M102.22M-4.43M57.90M
Operating Cash Flow983.11M812.82M591.76M381.52M240.83M221.42M
Investing Cash Flow-412.54M-403.75M-242.01M-304.90M-430.04M-197.97M
Financing Cash Flow2.08B-177.17M-93.26M-303.10M-61.52M544.46M

Xero Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price79.97
Price Trends
50DMA
95.84
Negative
100DMA
116.00
Negative
200DMA
145.23
Negative
Market Momentum
MACD
-4.94
Negative
RSI
42.80
Neutral
STOCH
81.96
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRO, the sentiment is Negative. The current price of 79.97 is below the 20-day moving average (MA) of 80.33, below the 50-day MA of 95.84, and below the 200-day MA of 145.23, indicating a bearish trend. The MACD of -4.94 indicates Negative momentum. The RSI at 42.80 is Neutral, neither overbought nor oversold. The STOCH value of 81.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:XRO.

Xero Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
AU$914.53M23.8565.33%10.16%25.67%744.90%
70
Outperform
$13.59B51.278.14%19.01%19.06%
69
Neutral
AU$15.13B62.5712.61%0.32%15.51%17.38%
65
Neutral
AU$1.23B33.3435.71%1.27%5.11%12.91%
63
Neutral
AU$8.17B61.8832.67%0.83%18.16%16.25%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
€1.34B17.5026.73%2.47%-4.10%341.80%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:XRO
Xero Limited
79.97
-94.13
-54.07%
AU:TNE
Technology One Limited
24.96
-4.64
-15.67%
AU:WTC
Wisetech Global
45.29
-44.49
-49.55%
AU:IRE
IRESS Limited
7.30
-0.60
-7.63%
AU:BVS
Bravura Solutions Limited
2.04
-0.21
-9.21%
AU:OCL
Objective Corporation Limited
12.78
-2.52
-16.47%

Xero Limited Corporate Events

Xero Sets Out Key FY27 Governance and Reporting Dates
Feb 22, 2026

Xero Limited has outlined its proposed key dates for the financial year ending 31 March 2027, giving investors and stakeholders a clear timetable for governance and reporting events. The schedule includes a 9 July 2026 deadline for director nominations to the Xero board and its annual meeting set for 27 August 2026.

The company plans to release its FY27 half-year results for the period to 30 September 2026 on 12 November 2026, followed by its full-year FY27 results on 20 May 2027. By setting out this timetable in advance, Xero provides greater visibility into its corporate calendar, supporting planning for shareholders, analysts and other market participants.

The most recent analyst rating on (AU:XRO) stock is a Hold with a A$79.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Issues 65,266 Unquoted Restricted Stock Units Under Employee Incentive Plan
Feb 3, 2026

Xero Limited has notified the market that it has issued 65,266 unquoted restricted stock units under its employee incentive scheme, with the securities coded XROAK and dated 28 January 2026. The new equity awards, which are subject to transfer restrictions and will not be quoted on the ASX until those restrictions lapse, underscore Xero’s continued use of equity-based remuneration to attract and retain staff, aligning employees’ interests with shareholders and potentially leading to future dilution once the securities vest and become tradable.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$210.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Issues Investor Briefing with Guidance on Use of Financial and Forward-Looking Information
Feb 2, 2026

Xero Limited has released an investor briefing presentation dated 3 February 2026, led by Chief Executive Officer Sukhinder Singh Cassidy and senior executives including the Chief Financial Officer, US CEO and Chief Product and Technology Officer, underscoring the company’s ongoing engagement with the investment community. The presentation outlines that the material is for general information only, is not an offer or recommendation to invest, may include non-GAAP financial measures, and contains forward-looking and past-performance statements that are subject to uncertainties, signalling a standard but important reminder to investors to interpret the company’s reported performance and outlook with caution and in conjunction with its formal financial reports and market releases.

The most recent analyst rating on (AU:XRO) stock is a Hold with a A$103.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Seeks ASX Quotation for New Tranche of Ordinary Shares
Jan 30, 2026

Xero Limited has applied to the ASX for quotation of a small tranche of new fully paid ordinary shares, totaling 51,876 securities issued on various dates between December 2025 and January 2026. The additional shares, arising from the exercise or conversion of existing options or other convertible securities, represent a minor increase in Xero’s listed capital base and reflect routine equity issuance activity rather than a major change in strategy or capital structure.

The most recent analyst rating on (AU:XRO) stock is a Hold with a A$105.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Reports Lapse of Restricted Stock Units and Options
Jan 28, 2026

Xero Limited has notified the market of the cessation of several equity-based instruments, including a total of 54,279 restricted stock units and 994 options, which have lapsed because their vesting or performance conditions were not met or became incapable of being satisfied between late November 2025 and mid-January 2026. The lapses reduce the pool of potential future shares under these incentive schemes and slightly tighten the company’s prospective issued capital base, signaling routine adjustments to its employee and executive equity plans without indicating any immediate operational or strategic shift.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$155.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Releases 1.26 Million Melio Acquisition Shares From Escrow
Jan 14, 2026

Xero Limited has announced that 1,255,936 securities issued on 21 November 2025 as part of its acquisition of Melio have been released from voluntary escrow and are now freely tradable, in line with the terms of the previously disclosed transaction. The company noted that this regulatory notice was lodged later than required under ASX Listing Rules due to an administrative oversight, highlighting a compliance lapse even as the post-acquisition integration phase sees these shares move into the market, potentially increasing Xero’s free float and liquidity for investors.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Issues New Shares to Finalise Melio Acquisition
Dec 30, 2025

Xero Limited has issued 49,032 fully paid ordinary shares to complete the previously announced acquisition of Melio Ltd, marking the share-based component of the transaction’s consideration. The company confirmed that the new shares were issued without a prospectus under the relevant Australian Corporations Act provisions, that it remains compliant with its financial reporting and continuous disclosure obligations, and that there is no excluded information that would affect the market, signalling a routine, regulatorily compliant equity issuance to support its expansion in small-business payments.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Seeks ASX Quotation for Additional 49,032 Ordinary Shares
Dec 30, 2025

Xero Limited has applied for quotation on the ASX of 49,032 new ordinary fully paid shares, to be issued on 31 December 2025. The additional securities, which stem from previously disclosed transactions, will modestly increase the company’s free float and share capital, potentially enhancing liquidity for investors while signalling ongoing use of equity-related arrangements within its capital management strategy.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero and Melio Announce Virtual Product Demonstration Session
Dec 9, 2025

Xero Limited has announced a virtual briefing session in collaboration with Melio, scheduled for February 3, 2026. The session will feature product demonstrations and educational segments aimed at investors and analysts, followed by a live Q&A. This initiative underscores Xero’s commitment to engaging with stakeholders and showcasing its product capabilities, potentially enhancing its market positioning and stakeholder relations.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$200.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Limited Expands Capital Base with New Securities Quotation
Dec 4, 2025

Xero Limited has announced the quotation of additional securities on the Australian Securities Exchange (ASX), with a total of 97,478 ordinary fully paid shares to be quoted. This move is part of the company’s ongoing efforts to enhance its financial flexibility and support its growth strategy, potentially impacting its market positioning by increasing its capital base.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$200.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Xero Limited Issues New Restricted Stock Units
Nov 27, 2025

Xero Limited has announced the issuance of 898,723 restricted stock units as part of a previously disclosed transaction. This move, which involves unquoted securities not intended for ASX listing, reflects the company’s ongoing strategy to manage its equity and incentivize stakeholders, potentially impacting its financial structure and market positioning.

The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 05, 2026